You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
AstraZeneca
Dow
Boehringer Ingelheim
Express Scripts
McKesson

Last Updated: February 16, 2020

DrugPatentWatch Database Preview

Litigation Details for Salix Pharmaceuticals, Inc v. Mylan Pharmaceuticals, Inc. (N.D.W. Va. 2015)


Email this page to a colleague

See Plans and Pricing

« Back to Dashboard

Salix Pharmaceuticals, Inc v. Mylan Pharmaceuticals, Inc. (N.D.W. Va. 2015)

Docket   Start Trial Date Filed 2015-06-26
Court District Court, N.D. West Virginia Date Terminated
Cause 35:271 Patent Infringement Assigned To Irene Patricia Murphy Keeley
Jury Demand None Referred To
Parties DR. FALK PHARMA GMBH; MYLAN PHARMACEUTICALS, INC.; MYLAN, INC.; SALIX PHARMACEUTICALS, INC
Patents 6,551,620; 8,337,886; 8,496,965; 8,865,688
Attorneys Anil H. Patel; Cedric C.Y. Tan; Christine I. Nam; Christopher A. Lauderman; Dana K. Severance; Daniel M. Attaway; George J Barry , III; Gordon H. Copland; James F. Companion; Jessica M. Hauth; Karen L. Carroll; Kristen H. Cramer; Mary W Bourke; Melanie Black Dubis; Micheal L. Binns; Robert L. Florence; Timothy H. Kratz; Tryn T. Stimart; William J O'Brien; Yolonda G. Lambert
Link to Docket External link to docket
Small Molecule Drugs cited in Salix Pharmaceuticals, Inc v. Mylan Pharmaceuticals, Inc.
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for Salix Pharmaceuticals, Inc v. Mylan Pharmaceuticals, Inc. (N.D.W. Va. 2015)

Date Filed Document No. Description Snippet Link To Document
2016-04-12 117 These include: Patent No. 6,551,620 (“the ‘620 Patent”); Patent No. 8,337,886 (“…the ‘886 Patent”); Patent No. 8,496,965 (“the ‘965 Patent”); and 8,865,688 (“the ‘688 Patent”). The …CONSTRUING PATENT CLAIMS This patent infringement case involves four United States patents issued …‘620, ‘886, and ‘965 Patents, collectively referred to as the Otterbeck patents,1 contain two disputed…dispute one claim term in the ‘688 Patent. The Otterbeck patents cover a controlled External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
McKesson
Dow
Merck
Johnson and Johnson
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.